Evaluation of Inflammatory Response System (IRS) and Compensatory Immune Response System (CIRS) in Adolescent Major Depression

References

• Institute of Health Metrics and Evaluation. Global Health Data Exchange (GHDx). Available from: http://ghdx.healthdata.org/gbd-results-tool?params=gbd-api-2019-permalink/d780dffbe8a381b25e1416884959e88b. Accessed August 11, 2022.
   Google Scholar
• Weinberger AH, Gbedemah M, Martinez AM, Nash D, Galea S, Goodwin RD. Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups. Psychol Med. 2018;48(8):1308–1315. doi:10.1017/S0033291717002781
   PubMed Web of Science ®Google Scholar
• Mojtabai R, Olfson M, Han B. National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics. 2016;138(6):e20161878. doi:10.1542/peds.2016-1878
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adolescent mental health. Available from: https://www.who.int/news-room/fact-sheets/detail/adolescent-mental-health. Accessed September 28, 2022.
   Google Scholar
• Zhou X, Teng T, Zhang Y, et al. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. The Lancet Psychiatry. 2020;7(7):581–601. doi:10.1016/S2215-0366(20)30137-1
   PubMed Web of Science ®Google Scholar
• Miller AH, Raison CL. Immune system contributions to the pathophysiology of depression. Focus. 2008;6(1):36–45. doi:10.1176/foc.6.1.foc36
   Google Scholar
• Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234–256. doi:10.1016/j.neuron.2020.06.002
   PubMed Web of Science ®Google Scholar
• Maes M, Van Der Planken M, Stevens WJ, et al. Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. J Psychiatr Res. 1992;26(2):125–134. doi:10.1016/0022-3956(92)90004-8
   PubMed Web of Science ®Google Scholar
• Köhler-Forsberg O, He W, Chang Y, Atlas SJ, Meigs JB, Nierenberg AA. White blood cell count at first depression diagnosis as predictor for risk of subsequent hospitalization with depression. Neurol Psychiatry Brain Res. 2017;26:1–6. doi:10.1016/j.npbr.2017.10.002
   Google Scholar
• Puangsri P, Ninla-Aesong P. Potential usefulness of complete blood count parameters and inflammatory ratios as simple biomarkers of depression and suicide risk in drug-naive, adolescents with major depressive disorder: simple peripheral markers for inflammation in drug-naive, adolescents with major depressive disorder. Psychiatry Res. 2021;305:114216. doi:10.1016/j.psychres.2021.114216
   PubMed Web of Science ®Google Scholar
• Uçar HN, Eray Ş, Murat D. Simple peripheral markers for inflammation in adolescents with major depressive disorder. Psych Clin Psychopharmacol. 2018;28:254–260. doi:10.1080/24750573.2018.1423769
   Web of Science ®Google Scholar
• Mazza MG, Lucchi S, Tringali AGM, Rossetti A, Botti ER, Clerici M. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84:229–236. doi:10.1016/j.pnpbp.2018.03.012
   PubMed Web of Science ®Google Scholar
• Demircan F, Gözel N, Kılınç F, Ulu R, Atmaca M. The impact of red blood cell distribution width and neutrophil/lymphocyte ratio on the diagnosis of major depressive disorder. Neurol Ther. 2016;5(1):27–33. doi:10.1007/s40120-015-0039-8
   PubMed Web of Science ®Google Scholar
• Demir S, Atli A, Bulut M, et al. Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy. Neuropsychiatr Dis Treat. 2015;11:2253–2258. doi:10.2147/NDT.S89470
   PubMed Web of Science ®Google Scholar
• Özyurt G, Binici NC. Increased neutrophil-lymphocyte ratios in depressive adolescents is correlated with the severity of depression. Psychiatry Res. 2018;268:426–431. doi:10.1016/j.psychres.2018.08.007
   PubMed Web of Science ®Google Scholar
• Maes M, Carvalho AF. The Compensatory Immune-Regulatory Reflex System (CIRS) in depression and bipolar disorder. Mol Neurobiol. 2018;55(12):8885–8903. doi:10.1007/s12035-018-1016-x
   PubMed Web of Science ®Google Scholar
• Debnath M, Berk M, Maes M. Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110343. doi:10.1016/j.pnpbp.2021.1103431
   PubMed Web of Science ®Google Scholar
• Classen A, Lloberas J, Celada A. Macrophage activation: classical vs. alternative. Methods Mol Biol. 2009;531:29–43. doi:10.1007/978-1-59745-396-7_3
   PubMedGoogle Scholar
• Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5–17. doi:10.1016/j.cyto.2014.09.011
   PubMed Web of Science ®Google Scholar
• Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 Macrophages and the Th1/Th2 Paradigm. J Immunol. 2000;164(12):6166–6173. doi:10.4049/jimmunol.164.12.6166
   PubMed Web of Science ®Google Scholar
• Tiemessen MM, Jagger AL, Evans HG, Van Herwijnen MJC, John S, Taams LS. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A. 2007;104(49):19446–19451. doi:10.1073/pnas.0706832104
   PubMed Web of Science ®Google Scholar
• Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimäki M. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206–215. doi:10.1016/j.bbi.2015.06.001
   PubMed Web of Science ®Google Scholar
• Howren MB, Lamkin DM, Suls J. Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171–186. doi:10.1097/PSY.0b013e3181907c1b
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. doi:10.1016/j.biopsych.2009.09.033
   PubMed Web of Science ®Google Scholar
• Köhler CA, Freitas TH, Maes M, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135(5):373–387. doi:10.1111/acps.12698
   PubMed Web of Science ®Google Scholar
• Liu Y, Ho RCM, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012;139(3):230–239. doi:10.1016/j.jad.2011.08.003
   PubMed Web of Science ®Google Scholar
• Valkanova V, Ebmeier KP, Allan CL. CRp, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150(3):736–744. doi:10.1016/j.jad.2013.06.004
   PubMed Web of Science ®Google Scholar
• Gabbay V, Klein RG, Alonso CM, et al. Immune system dysregulation in adolescent major depressive disorder. J Affect Disord. 2009;115(1–2):177–182. doi:10.1016/j.jad.2008.07.022
   PubMed Web of Science ®Google Scholar
• Henje Blom E, Lekander M, Ingvar M, Åsberg M, Mobarrez F, Serlachius E. Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. J Affect Disord. 2012;136(3):716–723. doi:10.1016/j.jad.2011.10.002
   PubMed Web of Science ®Google Scholar
• Lee H, Song M, Lee J, Kim JB, Lee MS. Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder. J Affect Disord. 2020;266:57–62. doi:10.1016/j.jad.2020.01.125
   PubMed Web of Science ®Google Scholar
• Byrne ML, O’Brien-Simpson NM, Reynolds EC, et al. Acute phase protein and cytokine levels in serum and saliva: a comparison of detectable levels and correlations in a depressed and healthy adolescent sample. Brain Behav Immun. 2013;34:164–175. doi:10.1016/j.bbi.2013.08.010
   PubMed Web of Science ®Google Scholar
• Pallavi P, Sagar R, Mehta M, et al. Serum cytokines and anxiety in adolescent depression patients: gender effect. Psychiatry Res. 2015;229(1–2):374–380. doi:10.1016/j.psychres.2015.06.036
   PubMed Web of Science ®Google Scholar
• Pérez-Sánchez G, Becerril-Villanueva E, Arreola R, et al. Inflammatory profiles in depressed adolescents treated with fluoxetine: an 8-week follow-up open study. Mediators Inflamm. 2018;2018:4074051. doi:10.1155/2018/4074051
   PubMed Web of Science ®Google Scholar
• Ho PS, Yen CH, Chen CY, Huang SY, Liang CS. Changes in cytokine and chemokine expression distinguish dysthymic disorder from major depression and healthy controls. Psychiatry Res. 2017;248:20–27. doi:10.1016/j.psychres.2016.12.014
   PubMed Web of Science ®Google Scholar
• Hung YJ, Hsieh CH, Chen YJ, et al. Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol. 2007;67(5):784–789. doi:10.1111/j.1365-2265.2007.02963.x
   PubMed Web of Science ®Google Scholar
• Miklowitz DJ, Portnoff LC, Armstrong CC, et al. Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders. Psychiatry Res. 2016;241:315–322. doi:10.1016/j.psychres.2016.04.120
   PubMed Web of Science ®Google Scholar
• Peters AT, Ren X, Bessette KL, et al. Interplay between pro-inflammatory cytokines, childhood trauma, and executive function in depressed adolescents. J Psychiatr Res. 2019;114:1–10. doi:10.1016/j.jpsychires.2019.03.030
   PubMed Web of Science ®Google Scholar
• Su SC, Sun MT, Wen MJ, Lin CJ, Chen YC, Hung YJ. Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men. Int J Psychiatry Med. 2011;42(3):211–226. doi:10.2190/PM.42.3.a
   PubMed Web of Science ®Google Scholar
• Belem da Silva CT, de Abreu Costa M, Kapczinski F, de Aguiar BW, Salum GA, Manfro GG. Inflammation and internalizing disorders in adolescents. Prog Neuropsychopharmacol Biol Psychiatry. 2017;77:133–137. doi:10.1016/j.pnpbp.2017.03.023
   PubMed Web of Science ®Google Scholar
• D’Acunto G, Nageye F, Zhang J, Masi G, Cortese S. Inflammatory cytokines in children and adolescents with depressive disorders: a systematic review and meta-Analysis. J Child Adolesc Psychopharmacol. 2019;29(5):362–369. doi:10.1089/cap.2019.0015
   PubMed Web of Science ®Google Scholar
• Toenders YJ, Laskaris L, Davey CG, et al. Inflammation and depression in young people: a systematic review and proposed inflammatory pathways. Mol Psychiatry. 2022;27(1):315–327. doi:10.1038/s41380-021-01306-8
   PubMed Web of Science ®Google Scholar
• Colasanto M, Madigan S, Korczak DJ. Depression and inflammation among children and adolescents: a meta-analysis. J Affect Disord. 2020;277:940–948. doi:10.1016/j.jad.2020.09.025
   PubMed Web of Science ®Google Scholar
• Howe AS, Lynch DA. Cytokine alterations in pediatric internalizing disorders: systematic review and exploratory multi-variate meta-analysis. Brain Behav Immun Heal. 2022;24. doi:10.1016/j.bbih.2022.100490
   Google Scholar
• Su S, Miller AH, Snieder H, et al. Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the twins heart study. Psychosom Med. 2009;71(2):152–158. doi:10.1097/PSY.0b013e31819082ef
   PubMed Web of Science ®Google Scholar
• Barnes J, Mondelli V, Pariante CM. Genetic contributions of inflammation to depression. Neuropsychopharmacology. 2017;42(1):81–98. doi:10.1038/npp.2016.169
   PubMed Web of Science ®Google Scholar
• Hwang JP, Tsai SJ, Hong CJ, Yang CH, Hsu CD, Liou YJ. Interleukin-1 beta −511C/T genetic polymorphism is associated with age of onset of geriatric depression. NeuroMolecular Med. 2009;11(4):322–327. doi:10.1007/s12017-009-8078-x
   PubMed Web of Science ®Google Scholar
• Baune BT, Dannlowski U, Domschke K, et al. The Interleukin 1 Beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry. 2010;67(6):543–549. doi:10.1016/j.biopsych.2009.11.004
   PubMed Web of Science ®Google Scholar
• Tartter M, Hammen C, Bower JE, Brennan PA, Cole S. Effects of chronic interpersonal stress exposure on depressive symptoms are moderated by genetic variation at IL6 and IL1β in youth. Brain Behav Immun. 2015;46:104–111. doi:10.1016/j.bbi.2015.01.003
   PubMed Web of Science ®Google Scholar
• Udina M, Moreno-España J, Navinés R, et al. Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms. Psychoneuroendocrinology. 2013;38(9):1803–1813. doi:10.1016/j.psyneuen.2013.03.007
   PubMed Web of Science ®Google Scholar
• Roetker NS, Yonker JA, Lee C, et al. Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study. BMJ Open. 2012;2(4):e000944. doi:10.1136/bmjopen-2012-000944
   PubMed Web of Science ®Google Scholar
• Clerici M, Arosio B, Mundo E, et al. Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectr. 2009;14(8):419–425. doi:10.1017/S1092852900020393
   PubMed Web of Science ®Google Scholar
• Holtzman S, Abbey SE, Chan C, Bargman JM, Stewart DE. A genetic predisposition to produce low levels of IL-10 is related to depressive symptoms: a pilot study of patients with end stage renal disease. Psychosomatics. 2012;53(2):155–161. doi:10.1016/j.psym.2011.10.001
   PubMed Web of Science ®Google Scholar
• Cerri AP, Arosio B, Viazzoli C, Confalonieri R, Teruzzi F, Annoni G. 308(G/A) TNF-alpha gene polymorphism and risk of depression late in the life. Arch Gerontol Geriatr. 2009;49(Suppl 1):29–34. doi:10.1016/j.archger.2009.09.009
   PubMed Web of Science ®Google Scholar
• Halder I, Marsland AL, Cheong J, Muldoon MF, Ferrell RE, Manuck SB. Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav Immun. 2010;24(1):160–167. doi:10.1016/j.bbi.2009.09.014
   PubMed Web of Science ®Google Scholar
• Ancelin ML, Farré A, Carrière I, Ritchie K, Chaudieu I, Ryan J. C-reactive protein gene variants: independent association with late-life depression and circulating protein levels. Transl Psychiatry. 2015;5(1):499.
   Web of Science ®Google Scholar
• Pae CU, Yu HS, Kim TS, et al. Monocyte chemoattractant protein-1 (MCP1) promoter −2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population. Psychiatry Res. 2004;127(3):279–281. doi:10.1016/j.psychres.2004.04.004
   PubMed Web of Science ®Google Scholar
• Altamura AC, Mundo E, Cattaneo E, et al. The MCP-1 Gene (SCYA2) and mood disorders: preliminary results of a case-control association study. Neuroimmunomodulation. 2010;17(2):126–131. doi:10.1159/000258696
   PubMed Web of Science ®Google Scholar
• Pae CU, Yu HS, Kim JJ, et al. BanI polymorphism of the cytosolic phospholipase A2 gene and mood disorders in the Korean population. Neuropsychobiology. 2004;49(4):185–188. doi:10.1159/000077364
   PubMed Web of Science ®Google Scholar
• Fertuzinhos SMM, Oliveira JRM, Nishimura AL, et al. Analysis of IL-1α, IL-1β, and IL-RA polymorphisms in dysthymia. J Mol Neurosci. 2004;22(3):251–255. doi:10.1385/JMN:22:3:251
   PubMed Web of Science ®Google Scholar
• McCulley MC, Day INM, Holmes C. Association between interleukin 1-β promoter (−511) polymorphism and depressive symptoms in Alzheimer’s disease. Am J Med Genet. 2004;124B(1):50–53. doi:10.1002/ajmg.b.20086
   PubMed Web of Science ®Google Scholar
• Yu YWY, Chen TJ, Hong CJ, Chen HM, Tsai SJ. Association study of the interleukin-Ibeta (C-5I IT) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology. 2003;28(6):1182–1185. doi:10.1038/sj.npp.1300172
   PubMed Web of Science ®Google Scholar
• Bufalino C, Hepgul N, Aguglia E, Pariante CM. The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain Behav Immun. 2013;31:31–47. doi:10.1016/j.bbi.2012.04.009
   PubMed Web of Science ®Google Scholar
• Wray NR, Ripke S, Mattheisen M, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50(5):668–681. doi:10.1038/s41588-018-0090-3
   PubMed Web of Science ®Google Scholar
• Zhao B, Fan Q, Liu J, Yin A, Wang P, Zhang W. Identification of key modules and genes associated with major depressive disorder in adolescents. Genes. 2022;13(3):464. doi:10.3390/genes13030464
   PubMed Web of Science ®Google Scholar
• Hannestad J, Dellagioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011;36(12):2452–2459. doi:10.1038/npp.2011.132
   PubMed Web of Science ®Google Scholar
• Wang L, Wang R, Liu L, Qiao D, Baldwin DS, Hou R. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: a systematic review and meta-analysis. Brain Behav Immun. 2019;79:24–38. doi:10.1016/j.bbi.2019.02.021
   PubMed Web of Science ®Google Scholar
• Więdłocha M, Marcinowicz P, Krupa R, et al. Effect of antidepressant treatment on peripheral inflammation markers – a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;80(Pt C):217–226. doi:10.1016/j.pnpbp.2017.04.026
   PubMed Web of Science ®Google Scholar
• Piletz JE, Halaris A, Iqbal O, et al. Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry. 2009;10(4):313–323. doi:10.3109/15622970802573246
   PubMed Web of Science ®Google Scholar
• Fornaro M, Martino M, Battaglia F, Colicchio S, Perugi G. Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation. Neuropsychiatr Dis Treat. 2011;7(1):51–56. doi:10.2147/NDT.S16382
   PubMed Web of Science ®Google Scholar
• Elenkov I, Wilder R, Chrousos G, Vizi E. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52(4):595–638.
   PubMed Web of Science ®Google Scholar
• Matveychuk D, Thomas RK, Swainson J, et al. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Ther Adv Psychopharmacol. 2020;10:2045125320916657. doi:10.1177/2045125320916657
   Web of Science ®Google Scholar
• Chen MH, Li CT, Lin WC, et al. Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study. Psychiatry Res. 2018;269:207–211. doi:10.1016/j.psychres.2018.08.078
   PubMed Web of Science ®Google Scholar
• Zhan Y, Zhou Y, Zheng W, et al. Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder. Transl Psychiatry. 2020;10(1):1–9. doi:10.1038/s41398-020-00933-z
   PubMed Web of Science ®Google Scholar
• Becerril-Villanueva E, Pérez-Sánchez G, Alvarez-Herrera S, et al. Alterations in the levels of growth factors in adolescents with major depressive disorder: a longitudinal study during the treatment with fluoxetine. Mediators Inflamm. 2019;2019:9130868. doi:10.1155/2019/9130868
   PubMed Web of Science ®Google Scholar
• Amitai M, Taler M, Carmel M, et al. The relationship between plasma cytokine levels and response to selective serotonin reuptake inhibitor treatment in children and adolescents with depression and/or anxiety disorders. J Child Adolesc Psychopharmacol. 2016;26(8):727–732. doi:10.1089/cap.2015.0147
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–1917. doi:10.1176/ajp.2006.163.11.1905
   PubMed Web of Science ®Google Scholar
• Jha MK, Trivedi MH. Pharmacogenomics and biomarkers of depression. In: Macaluso M, Preskorn S, editors. Antidepressants. Handbook of Experimental Pharmacology. Cham: Springer; 2019:101–113.
   Google Scholar
• Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised Phase III trial. Lancet. 2006;367(9504):29–35. doi:10.1016/S0140-6736(05)67763-X
   PubMed Web of Science ®Google Scholar
• Menter A, Augustin M, Signorovitch J, et al. The effect of Adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. J Am Acad Dermatol. 2010;62(5):812–818. doi:10.1016/j.jaad.2009.07.022
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang D, Salvadore G, et al. The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman’s disease. Brain Behav Immun. 2017;66:156–164. doi:10.1016/j.bbi.2017.06.014
   PubMed Web of Science ®Google Scholar
• Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry. 2018;23(2):335–343. doi:10.1038/mp.2016.167
   PubMed Web of Science ®Google Scholar
• Berk M, Mohebbi M, Dean OM, et al. Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin. BMC Med. 2020;18(1):16. doi:10.1186/s12916-019-1475-6
   PubMed Web of Science ®Google Scholar
• Platt JM, Bates L, Jager J, McLaughlin KA, Keyes KM. Is the US Gender gap in depression changing over time? A meta-regression. Am J Epidemiol. 2021;190(7):1190–1206. doi:10.1093/aje/kwab002
   PubMed Web of Science ®Google Scholar
• Hankin BL, Young JF, Abela JRZ, et al. Depression from childhood into late adolescence: influence of gender, development, genetic susceptibility, and peer stress. J Abnorm Psychol. 2015;124(4):803–816. doi:10.1037/abn0000089
   PubMed Web of Science ®Google Scholar
• Xing E, Billi AC, Gudjonsson JE. Sex bias and autoimmune diseases. J Invest Dermatol. 2022;142(3):857–866. doi:10.1016/j.jid.2021.06.008
   PubMed Web of Science ®Google Scholar
• Gimeno D, Kivimäki M, Brunner EJ, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-Year follow-up of the Whitehall II study. Psychol Med. 2009;39(3):413–423. doi:10.1017/S0033291708003723
   PubMed Web of Science ®Google Scholar
• Koskinas J, Merkouraki P, Manesis E, Hadziyannis S. Assessment of depression in patients with chronic viral hepatitis: effect of interferon treatment. Dig Dis. 2002;20(3–4):284–288. doi:10.1159/000067682
   PubMed Web of Science ®Google Scholar
• Bremmer MA, Beekman ATF, Deeg DJH, et al. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord. 2008;106(3):249–255. doi:10.1016/j.jad.2007.07.002
   PubMed Web of Science ®Google Scholar
• Bonaccorso S, Marino V, Puzella A, et al. Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-α-induced changes in the serotonergic system. J Clin Psychopharmacol. 2002;22(1):86–90. doi:10.1097/00004714-200202000-00014
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM–5). 5th ed. Arlington, VA, USA: American Psychiatric Publishing; 2013.
   Google Scholar
• Kovacs M. Children´s Depression Inventory. CDI Manual. Toronto, Ontario, Canada: Multi-Health Systems; 1992.
   Google Scholar
• Guimarães PM, Scavuzzi BM, Stadtlober NP, et al. Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles. Immunol Cell Biol. 2017;95(9):824–831. doi:10.1038/icb.2017.53
   PubMed Web of Science ®Google Scholar
• Andrade C. Z scores, standard scores, and composite test scores explained. Indian J Psychol Med. 2021;43(6):555–557. doi:10.1177/02537176211046525
   PubMedGoogle Scholar
• Brunoni AR, Supasitthumrong T, Teixeira AL, et al. Differences in the immune-inflammatory profiles of unipolar and bipolar depression. J Affect Disord. 2020;262:8–15. doi:10.1016/j.jad.2019.10.037
   PubMed Web of Science ®Google Scholar
• Chiang JJ, Cole SW, Bower JE, et al. Depressive symptoms and immune transcriptional profiles in late adolescents. Brain Behav Immun. 2019;80:163–169. doi:10.1016/j.bbi.2019.03.004
   PubMed Web of Science ®Google Scholar
• Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 2003;14(3–4):185–191. doi:10.1016/S1359-6101(03)00022-4
   PubMed Web of Science ®Google Scholar
• Olmos G, Lladó J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014;2014:861231. doi:10.1155/2014/861231
   PubMed Web of Science ®Google Scholar
• Gough P, Myles IA. Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects. Front Immunol. 2020;11:585880. doi:10.3389/fimmu.2020.585880
   PubMed Web of Science ®Google Scholar
• Chemaly M, McGilligan V, Gibson M, et al. Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events. Arch Cardiovasc Dis. 2017;110(12):700–711. doi:10.1016/j.acvd.2017.08.002
   PubMed Web of Science ®Google Scholar
• Sedger LM, McDermott MF. TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev. 2014;25(4):453–472. doi:10.1016/j.cytogfr.2014.07.016
   PubMed Web of Science ®Google Scholar
• Gómez MI, Sokol SH, Muir AB, Soong G, Bastien J, Prince AS. Bacterial induction of TNF-α converting enzyme expression and IL-6 receptor α shedding regulates airway inflammatory signaling. J Immunol. 2005;175(3):1930–1936. doi:10.4049/jimmunol.175.3.1930
   PubMed Web of Science ®Google Scholar
• Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol. 1992;149(6):2021–2027.
   PubMed Web of Science ®Google Scholar
• Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta Mol Cell Res. 2011;1813(5):878–888. doi:10.1016/j.bbamcr.2011.01.034
   PubMed Web of Science ®Google Scholar
• Hurst SM, Wilkinson TS, McLoughlin RM, et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 2001;14(6):705–714. doi:10.1016/S1074-7613(01)00151-0
   PubMed Web of Science ®Google Scholar
• Maes M, Anderson G, Kubera M, Berk M. Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert Opin Ther Targets. 2014;18(5):495–512. doi:10.1517/14728222.2014.888417
   PubMed Web of Science ®Google Scholar
• Sowa-Kućma M, Styczeń K, Siwek M, et al. Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia. Neurotox Res. 2018;33(2):448–460. doi:10.1007/s12640-017-9835-5
   PubMed Web of Science ®Google Scholar
• Sowa-Kućma M, Styczeń K, Siwek M, et al. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry. 2018;81:372–383. doi:10.1016/j.pnpbp.2017.08.024
   PubMed Web of Science ®Google Scholar
• Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226(1):205–218. doi:10.1111/j.1600-065X.2008.00706.x
   PubMed Web of Science ®Google Scholar
• Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180(9):5771–5777. doi:10.4049/jimmunol.180.9.5771
   PubMed Web of Science ®Google Scholar
• Luzina IG, Keegan AD, Heller NM, Rook GAW, Shea-Donohue T, Atamas SP. Regulation of inflammation by interleukin-4: a review of “alternatives”. J Leukoc Biol. 2012;92(4):753–764. doi:10.1189/jlb.0412214
   PubMed Web of Science ®Google Scholar
• Ogłodek E. Changes in the serum levels of cytokines: IL-1β, IL-4, IL-8 and IL-10 in depression with and without posttraumatic stress disorder. Brain Sci. 2022;12(3):387. doi:10.3390/BRAINSCI12030387
   PubMed Web of Science ®Google Scholar
• Maes M, Rachayon M, Jirakran K, et al. The immune profile of major dysmood disorder: proof of concept and mechanism using the precision nomothetic psychiatry approach. Cells. 2022;11(7):1183. doi:10.3390/cells11071183
   PubMed Web of Science ®Google Scholar
• Maes M, Berk M, Goehler L, et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012;10:66. doi:10.1186/1741-7015-10-66
   PubMed Web of Science ®Google Scholar
• Das R, Emon MPZ, Shahriar M, et al. Higher levels of serum IL-1β and TNF-α are associated with an increased probability of major depressive disorder. Psychiatry Res. 2021;295:113568. doi:10.1016/j.psychres.2020.113568
   PubMed Web of Science ®Google Scholar
• Moieni M, Irwin MR, Jevtic I, Olmstead R, Breen EC, Eisenberger NI. Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology. 2015;40(7):1709–1716. doi:10.1038/npp.2015.17
   PubMed Web of Science ®Google Scholar
• Kim J, Kim JH, Chang KA. Sex difference in peripheral inflammatory biomarkers in drug-naïve patients with major depression in young adulthood. Biomedicines. 2021;9(7):708. doi:10.3390/biomedicines9070708
   PubMed Web of Science ®Google Scholar
• Zainal NH, Newman MG. Increased inflammation predicts nine-year change in major depressive disorder diagnostic status. J Abnorm Psychol. 2021;130(8):829–840. doi:10.1037/abn0000716
   PubMed Web of Science ®Google Scholar
• Birur B, Amrock EM, Shelton RC, Li L. Sex differences in the peripheral immune system in patients with depression. Front Psychiatry. 2017;8:16. doi:10.3389/fpsyt.2017.00108
   PubMed Web of Science ®Google Scholar
• Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004;164(9):1010–1014. doi:10.1001/archinte.164.9.1010
   PubMedGoogle Scholar
• Ramsey JM, Cooper JD, Bot M, et al. Sex differences in serum markers of major depressive disorder in the Netherlands Study of Depression and Anxiety (NESDA). PLoS One. 2016;11(5):e0156624. doi:10.1371/journal.pone.0156624
   PubMed Web of Science ®Google Scholar
• Valiathan R, Ashman M, Asthana D. Effects of ageing on the immune system: infants to elderly. Scand J Immunol. 2016;83(4):255–266. doi:10.1111/sji.12413
   PubMed Web of Science ®Google Scholar
• West LS. Defining critical windows in the development of the human immune system. Hum Exp Toxicol. 2002;21(9–10):499–505. doi:10.1191/0960327102ht288oa
   PubMed Web of Science ®Google Scholar
• Shames RS. Gender differences in the development and function of the immune system. J Adolesc Health. 2002;30:59–70. doi:10.1016/S1054-139X(01)00382-2
   PubMed Web of Science ®Google Scholar
• Traish A, Bolanos J, Nair S, Saad F, Morgentaler A. Do androgens modulate the pathophysiological pathways of inflammation? Appraising the contemporary evidence. J Clin Med. 2018;7(12):549. doi:10.3390/jcm7120549
   PubMed Web of Science ®Google Scholar
• Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–574. doi:10.1210/er.2007-0001
   PubMed Web of Science ®Google Scholar
• Schwarz MJ. Cytokines, neurophysiology, neuropsychology, and psychiatric symptoms. Dialogues Clin Neurosci. 2003;5(2):139–153. doi:10.31887/dcns.2003.5.2/mschwarz
   PubMedGoogle Scholar
• Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immun. 2007;21(6):727–735. doi:10.1016/j.bbi.2007.05.005
   PubMed Web of Science ®Google Scholar
• Watkins LR, Goehler LE, Relton JK, et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett. 1995;183(1–2):27–31. doi:10.1016/0304-3940(94)11105-R
   PubMed Web of Science ®Google Scholar
• D’Mello C, Le T, Swain MG. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factorα signaling during peripheral organ inflammation. J Neurosci. 2009;29(7):2089–2102. doi:10.1523/JNEUROSCI.3567-08.2009
   PubMed Web of Science ®Google Scholar
• Huang X, Hussain B, Chang J. Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms. CNS Neurosci Ther. 2021;27(1):36–47. doi:10.1111/cns.13569
   PubMed Web of Science ®Google Scholar
• Bakunina N, Pariante CM, Zunszain PA. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology. 2015;144(3):365–373. doi:10.1111/imm.12443
   PubMed Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–741. doi:10.1016/j.biopsych.2008.11.029
   PubMed Web of Science ®Google Scholar
• Tonhajzerova I, Sekaninova N, Bona Olexova L, Visnovcova Z. Novel insight into neuroimmune regulatory mechanisms and biomarkers linking major depression and vascular diseases: the dilemma continues. Int J Mol Sci. 2020;21(7):2317. doi:10.3390/ijms21072317
   PubMed Web of Science ®Google Scholar
• Anderson G, Maes M. Oxidative/Nitrosative stress and immuno-inflammatory pathways in depression: treatment implications. Curr Pharm Des. 2014;20(23):3812–3847. doi:10.2174/13816128113196660738
   PubMed Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56. doi:10.1038/nrn2297
   PubMed Web of Science ®Google Scholar
• Camacho-Arroyo I, López-Griego L, Morales-Montor J. The role of cytokines in the regulation of neurotransmission. Neuroimmunomodulation. 2009;16(1):1–12. doi:10.1159/000179661
   PubMed Web of Science ®Google Scholar
• Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry. 2002;7(5):468–473. doi:10.1038/sj.mp.4000995
   PubMed Web of Science ®Google Scholar
• Munn DH, Mellor AL. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol. 2013;34(3):137–143. doi:10.1016/j.it.2012.10.001
   PubMed Web of Science ®Google Scholar
• Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev. 2018;98(1):477–504. doi:10.1152/physrev.00039.2016
   PubMed Web of Science ®Google Scholar
• Walker AK, Budac DP, Bisulco S, et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology. 2013;38(9):1609–1616. doi:10.1038/npp.2013.71
   PubMed Web of Science ®Google Scholar
• Sattar Y, Wilson J, Khan AM, et al. A review of the mechanism of antagonism of N-methyl-D-aspartate receptor by ketamine in treatment-resistant depression. Cureus. 2018;10(5):e2652. doi:10.7759/cureus.2652
   PubMed Web of Science ®Google Scholar
• Baganz NL, Blakely RD. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci. 2013;4(1):48–63. doi:10.1021/cn300186b
   PubMed Web of Science ®Google Scholar
• Bin ZC, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology. 2006;31(10):2121–2131. doi:10.1038/sj.npp.1301029
   PubMed Web of Science ®Google Scholar
• Cowen PJ, Browning M. What has serotonin to do with depression? World Psychiatry. 2015;14(2):158–160. doi:10.1002/wps.20229
   PubMed Web of Science ®Google Scholar
• Müller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry. 2007;12(11):988–1000. doi:10.1038/sj.mp.4002006
   PubMed Web of Science ®Google Scholar